Literature DB >> 23881289

Diphenyl diselenide prevents cortico-cerebral mitochondrial dysfunction and oxidative stress induced by hypercholesterolemia in LDL receptor knockout mice.

Jade de Oliveira1, Eduardo Luiz Gasnhar Moreira, Gianni Mancini, Mariana Appel Hort, Alexandra Latini, Rosa Maria Ribeiro-do-Valle, Marcelo Farina, João Batista Teixeira da Rocha, Andreza Fabro de Bem.   

Abstract

Recent studies have indicated a causal link between high dietary cholesterol intake and brain oxidative stress. In particular, we have previously shown a positive correlation between elevated plasma cholesterol levels, cortico-cerebral oxidative stress and mitochondrial dysfunction in low density lipoprotein receptor knockout (LDLr(-/-)) mice, a mouse model of familial hypercholesterolemia. Here we show that the organoselenium compound diphenyl diselenide (PhSe)2 (1 mg/kg; o.g., once a day for 30 days) significantly blunted the cortico-cerebral oxidative stress and mitochondrial dysfunction induced by a hypercholesterolemic diet in LDLr(-/-) mice. (PhSe)2 effectively prevented the inhibition of complex I and II activities, significantly increased the reduced glutathione (GSH) content and reduced lipoperoxidation in the cerebral cortex of hypercholesterolemic LDLr(-/-) mice. Overall, (PhSe)2 may be a promising molecule to protect against hypercholesterolemia-induced effects on the central nervous system, in addition to its already demonstrated antiatherogenic effects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23881289     DOI: 10.1007/s11064-013-1110-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  79 in total

1.  Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress.

Authors:  J de Oliveira; M A Hort; E L G Moreira; V Glaser; R M Ribeiro-do-Valle; R D Prediger; M Farina; A Latini; A F de Bem
Journal:  Neuroscience       Date:  2011-09-16       Impact factor: 3.590

2.  Oxidative stress related changes in the brain of hypercholesterolemic rabbits.

Authors:  Nurgül Aytan; Tobias Jung; Faruk Tamtürk; Tilman Grune; Nesrin Kartal-Ozer
Journal:  Biofactors       Date:  2008       Impact factor: 6.113

3.  Mild hypercholesterolemia, normal plasma triglycerides, and normal glucose levels across dementia staging in Alzheimer's disease: a clinical setting-based retrospective study.

Authors:  Said Ramdane; Doria Daoudi-Gueddah
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-06-29       Impact factor: 2.035

4.  Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial.

Authors:  D L Sparks; D J Connor; M N Sabbagh; R B Petersen; J Lopez; P Browne
Journal:  Acta Neurol Scand Suppl       Date:  2006

5.  Oxidative stress in hypercholesterolemic LDL (low-density lipoprotein) receptor knockout mice is associated with low content of mitochondrial NADP-linked substrates and is partially reversed by citrate replacement.

Authors:  Bruno A Paim; Jesus A Velho; Roger F Castilho; Helena C F Oliveira; Aníbal E Vercesi
Journal:  Free Radic Biol Med       Date:  2007-10-16       Impact factor: 7.376

6.  Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport.

Authors:  A Cassina; R Radi
Journal:  Arch Biochem Biophys       Date:  1996-04-15       Impact factor: 4.013

7.  Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-kappaB activation.

Authors:  Montserrat Marí; Anna Colell; Albert Morales; Francisco Caballero; Anna Moles; Anna Fernández; Oihana Terrones; Gorka Basañez; Bruno Antonsson; Carmen García-Ruiz; José C Fernández-Checa
Journal:  Gastroenterology       Date:  2008-01-31       Impact factor: 22.682

8.  Mitochondrial alterations in Alzheimer's disease.

Authors:  Stavros J Baloyannis; Vassiliki Costa; Demetrios Michmizos
Journal:  Am J Alzheimers Dis Other Demen       Date:  2004 Mar-Apr       Impact factor: 2.035

9.  The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study.

Authors:  J Stokes; W B Kannel; P A Wolf; L A Cupples; R B D'Agostino
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

Review 10.  An imbalance in antioxidant defense affects cellular function: the pathophysiological consequences of a reduction in antioxidant defense in the glutathione peroxidase-1 (Gpx1) knockout mouse.

Authors:  Judy B De Haan; Peter J Crack; Nicole Flentjar; Rocco C Iannello; Paul J Hertzog; Ismail Kola
Journal:  Redox Rep       Date:  2003       Impact factor: 4.412

View more
  12 in total

Review 1.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

2.  Guanosine Prevents Anhedonic-Like Behavior and Impairment in Hippocampal Glutamate Transport Following Amyloid-β1-40 Administration in Mice.

Authors:  Débora Lanznaster; Josiel M Mack; Victor Coelho; Marcelo Ganzella; Roberto F Almeida; Tharine Dal-Cim; Gisele Hansel; Eduardo R Zimmer; Diogo O Souza; Rui D Prediger; Carla I Tasca
Journal:  Mol Neurobiol       Date:  2016-09-06       Impact factor: 5.590

Review 3.  The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.

Authors:  Seyed Soheil Saeedi Saravi; Seyed Sobhan Saeedi Saravi; Alireza Arefidoust; Ahmad Reza Dehpour
Journal:  Metab Brain Dis       Date:  2017-06-03       Impact factor: 3.584

Review 4.  Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.

Authors:  Yajun Duan; Ke Gong; Suowen Xu; Feng Zhang; Xianshe Meng; Jihong Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-02

5.  Global loss of acetylcholinesterase activity with mitochondrial complexes inhibition and inflammation in brain of hypercholesterolemic mice.

Authors:  Rajib Paul; Anupom Borah
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

6.  Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.

Authors:  Rajib Paul; Amarendranath Choudhury; Sanjeev Kumar; Anirudha Giri; Rajat Sandhir; Anupom Borah
Journal:  PLoS One       Date:  2017-02-07       Impact factor: 3.240

7.  Reduced cognitive function, increased blood-brain-barrier transport and inflammatory responses, and altered brain metabolites in LDLr -/-and C57BL/6 mice fed a western diet.

Authors:  Jennifer M Rutkowsky; Linda L Lee; Michelle Puchowicz; Mari S Golub; Douglas E Befroy; Dennis W Wilson; Steven Anderson; Gary Cline; Jason Bini; Kamil Borkowski; Trina A Knotts; John C Rutledge
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

Review 8.  Functional Roles of the Interaction of APP and Lipoprotein Receptors.

Authors:  Theresa Pohlkamp; Catherine R Wasser; Joachim Herz
Journal:  Front Mol Neurosci       Date:  2017-03-01       Impact factor: 5.639

9.  Evaluation of the In Vivo and In Vitro Effects of Fructose on Respiratory Chain Complexes in Tissues of Young Rats.

Authors:  Ernesto António Macongonde; Thais Ceresér Vilela; Giselli Scaini; Cinara Ludvig Gonçalves; Bruna Klippel Ferreira; Naithan Ludian Fernandes Costa; Marcos Roberto de Oliveira; Silvio Avila Junior; Emilio Luiz Streck; Gustavo Costa Ferreira; Patrícia Fernanda Schuck
Journal:  Dis Markers       Date:  2015-12-06       Impact factor: 3.434

10.  High Cholesterol Diet Exacerbates Blood-Brain Barrier Disruption in LDLr-/- Mice: Impact on Cognitive Function.

Authors:  Jade de Oliveira; Daiane F Engel; Gabriela C de Paula; Danúbia B Dos Santos; Jadna B Lopes; Marcelo Farina; Eduardo L G Moreira; Andreza F de Bem
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.